An Explorative Study on Calcium Electroporation for Low-risk Basal Cell Carcinoma
DOI:
https://doi.org/10.2340/actadv.v104.19678Keywords:
Calcium electroporation, Basal cell carcinoma, electrochemotherapy, high frequency electroporationAbstract
In electrochemotherapy, permeabilization of the cell membrane by electric pulses increases the anti-tumour effect of chemotherapeutics. In calcium electroporation, chemotherapy is replaced by calcium chloride with obvious benefits. This study explores the effect and underlying mechanisms of calcium electroporation on basal cell carcinomas using either high- or low-frequency electroporation. Low-risk primary basal cell carcinomas were treated in local anaesthesia with intratumoral calcium chloride followed by electroporation with high (167 kHz) or low (5 kHz) frequencies. Non-complete responders were retreated after 3 months. The primary endpoint was tumour response 3 months after last calcium electroporation. Plasma membrane calcium ATPase was examined in various cell lines as plasma membrane calcium ATPase levels have been associated with calcium electroporation efficacy. Twenty-two out of 25 included patients complete the study and 7 of these (32%) achieved complete response at 3 months with no difference in efficacy between high- and low-frequency pulses. High-frequency calcium electroporation was significantly less painful (p=0.03). Plasma membrane calcium ATPase was increased 16–32-fold in basal cell carcinoma cell lines compared with 4 other cancer cell lines. Calcium electroporation for low-risk basal cell carcinomas does not fulfil the requirements of a new dermatological basal cell carcinoma treatment but may be useful as adjuvant treatment to surgery in more advanced basal cell carcinomas. The elevated PMCA levels in basal cell carcinomas may contribute to low efficacy.
Downloads
References
Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ. Basal cell carcinoma: what's new under the sun. Photochem Photobiol 2010; 86: 481-491.
https://doi.org/10.1111/j.1751-1097.2010.00735.x DOI: https://doi.org/10.1111/j.1751-1097.2010.00735.x
Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 2017; 177: 359-372.
https://doi.org/10.1111/bjd.15321 DOI: https://doi.org/10.1111/bjd.15321
Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118: 10-34.
https://doi.org/10.1016/j.ejca.2019.06.003 DOI: https://doi.org/10.1016/j.ejca.2019.06.003
Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-447.
https://doi.org/10.1046/j.1365-201X.2003.01093.x DOI: https://doi.org/10.1046/j.1365-201X.2003.01093.x
Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019). Eur J Cancer 2020; 138: 30-40.
https://doi.org/10.1016/j.ejca.2020.06.020 DOI: https://doi.org/10.1016/j.ejca.2020.06.020
Frandsen SK, Vissing M, Gehl J. A comprehensive review of calcium electroporation: a novel cancer treatment modality. Cancers 2020; 12: 290.
https://doi.org/10.3390/cancers12020290 DOI: https://doi.org/10.3390/cancers12020290
Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 2012; 72: 1336-1341.
https://doi.org/10.1158/0008-5472.CAN-11-3782 DOI: https://doi.org/10.1158/0008-5472.CAN-11-3782
Frandsen SK, Krüger MB, Mangalanathan UM, Tramm T, Mahmood F, Novak I, et al. Normal and malignant cells exhibit differential responses to calcium electroporation. Cancer Res 2017; 77: 4389-4401.
https://doi.org/10.1158/0008-5472.CAN-16-1611 DOI: https://doi.org/10.1158/0008-5472.CAN-16-1611
Falk H, Matthiessen LW, Wooler G, Gehl J. Calcium electroporation for treatment of cutaneous metastasis: a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy. Acta Oncol 2018; 57: 311-319.
https://doi.org/10.1080/0284186X.2017.1355109 DOI: https://doi.org/10.1080/0284186X.2017.1355109
Ágoston D, Baltás E, Ócsai H, Rátkai S, Lázár PG, Korom I, et al. Evaluation of calcium electroporation for the treatment of cutaneous metastases: a double blinded randomised controlled phase II trial. Cancers 2020; 12: 179.
https://doi.org/10.3390/cancers12010179 DOI: https://doi.org/10.3390/cancers12010179
Vissing M, Pervan M, Ploen J, Schnefeldt M, Rafaelsen SR, Jensen LH, et al. Calcium electroporation in cutaneous metastases: a non-randomised phase II multicentre clinical trial. Eur J Surg Oncol 2023; 49: 106925.
https://doi.org/10.1016/j.ejso.2023.04.024 DOI: https://doi.org/10.1016/j.ejso.2023.04.024
Plaschke CC, Gehl J, Johannesen HH, Fischer BM, Kjaer A, Lomholt AF, et al. Calcium electroporation for recurrent head and neck cancer: a clinical phase I study. Laryngoscope Investig Otolaryngol 2019; 4: 49-56.
https://doi.org/10.1002/lio2.233 DOI: https://doi.org/10.1002/lio2.233
Egeland C, Baeksgaard L, Gehl J, Gögenur I, Achiam MP. Palliative treatment of esophageal cancer using calcium electroporation. Cancers 2022; 14: 5283.
https://doi.org/10.3390/cancers14215283 DOI: https://doi.org/10.3390/cancers14215283
Broholm M, Vogelsang R, Bulut M, Stigaard T, Falk H, Frandsen S, et al. Endoscopic calcium electroporation for colorectal cancer: a phase I study. Endosc Int Open 2023; 11: E451-459.
https://doi.org/10.1055/a-2033-9831 DOI: https://doi.org/10.1055/a-2033-9831
Gibot L, Montigny A, Baaziz H, Fourquaux I, Audebert M, Rols M-P. Calcium delivery by electroporation induces in vitro cell death through mitochondrial dysfunction without DNA damages. Cancers 2020; 12: 425.
https://doi.org/10.3390/cancers12020425 DOI: https://doi.org/10.3390/cancers12020425
Noubissi FK, Kim T, Kawahara TN, Aughenbaugh WD, Berg E, Longley BJ, et al. Role of CRD-BP in the growth of human basal cell carcinoma cells. J Invest Dermatol 2014; 134: 1718-1724.
https://doi.org/10.1038/jid.2014.17 DOI: https://doi.org/10.1038/jid.2014.17
Olesen UH, Bojesen S, Gehl J, Haedersdal M. Anticancer drugs and the regulation of Hedgehog genes GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell lines. Anticancer Drugs 2017; 28: 1106-1117.
https://doi.org/10.1097/CAD.0000000000000551 DOI: https://doi.org/10.1097/CAD.0000000000000551
Hendel K, Jemec GBE, Haedersdal M, Wiegell SR. Electrochemotherapy with bleomycin for basal cell carcinomas: a systemic review. J Eur Acad Dermatol Venereol 2021; 35: 2208-2215.
https://doi.org/10.1111/jdv.17492 DOI: https://doi.org/10.1111/jdv.17492
Clover AJP, Salwa SP, Bourke MG, McKiernan J, Forde PF, O'Sullivan ST, et al. Electrochemotherapy for the treatment of primary basal cell carcinoma: a randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol 2020; 46: 847-854.
https://doi.org/10.1016/j.ejso.2019.11.509 DOI: https://doi.org/10.1016/j.ejso.2019.11.509
Ahmed-Salim Y, Saso S, Meehan HE, Galazis N, Phelps DL, Jones BP et al. A novel application of calcium electroporation to cutaneous manifestations of gynaecological cancer. Eur J Gynaecol Oncol 2021; 42: 662-672.
https://doi.org/10.31083/j.ejgo4204102 DOI: https://doi.org/10.31083/j.ejgo4204102
Hansen HF, Bourke M, Stigaard T, Clover J, Buckley M, O'Riordain M, et al. Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study. Endosc Int Open 2020; 8: E124-E132.
https://doi.org/10.1055/a-1027-6735 DOI: https://doi.org/10.1055/a-1027-6735
Ulrich M, von Braunmuehl T, Kurzen H, Dirschka T, Kellner C, Sattler E, et al. The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study. Br J Dermatol 2015; 173: 428-435.
https://doi.org/10.1111/bjd.13853 DOI: https://doi.org/10.1111/bjd.13853
Lin C-Y, Hsieh K-C, Yeh MC, Sheen-Chen S-M, Chou F-F. Skin necrosis after intravenous calcium chloride administration as a complication of parathyroidectomy for secondary hyperparathyroidism: report of four cases. Surg Today 2007; 37: 778-781.
https://doi.org/10.1007/s00595-006-3426-z DOI: https://doi.org/10.1007/s00595-006-3426-z
Kim MP, Raho VJ, Mak J, Kaynar AM. Skin and soft tissue necrosis from calcium chloride in a deicer. J Emergency Med 2007; 32: 41-44.
https://doi.org/10.1016/j.jemermed.2006.05.030 DOI: https://doi.org/10.1016/j.jemermed.2006.05.030
Taogoshi T, Shibata Y, Uno H, Yokooji T, Tanaka M, Hide M, et al. Classification of skin injury risk caused by extravasation of electrolyte solutions or infusions in a rat model. Biol Pharm Bull 2022; 45: 1254-1258.
https://doi.org/10.1248/bpb.b22-00170 DOI: https://doi.org/10.1248/bpb.b22-00170
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Stine R. Wiegell, Kristoffer Hendel, Christine S.K. Fuchs, Julie Gehl, Mille Vissing, Sara W. Bro, Jesper T. Troelsen, Gregor B.E. Jemec, Merete Haedersdal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
